[1]
|
Weinberg, O.K. and Arber, D.A. (2010) Mixed-Phenotype Acute Leukemia: Historical Overview and a New Definition. Leukemia, 24, 1844-1851. https://doi.org/10.1038/leu.2010.202
|
[2]
|
Khan, M., Siddiqi, R. and Naqvi, K. (2018) An Update on Classification, Genetics, and Clinical Approach to Mixed Phenotype Acute Leukemia (MPAL). Annals of Hematology, 97, 945-953. https://doi.org/10.1007/s00277-018-3297-6
|
[3]
|
Wolach, O. and Stone, R.M. (2017) Mixed-Phenotype Acute Leukemia: Current Challenges in Diagnosis and Therapy. Current Opinion in Hematology, 24, 139-145. https://doi.org/10.1097/MOH.0000000000000322
|
[4]
|
Takahashi, K., Wang, F., Morita, K., Yan, Y., Hu, P., Zhao, P., et al. (2018) Integrative Genomic Analysis of Adult Mixed Phenotype Acute Leukemia Delineates Lineage Associated Molecular Subtypes. Nature Communications, 9, Article No. 2670. https://doi.org/10.1038/s41467-018-04924-z
|
[5]
|
Andrews, C., Tierens, A. and Minden, M. (2021) The Genomic and Biological Complexity of Mixed Phenotype Acute Leukemia. Critical Reviews in Clinical Laboratory Sciences, 58, 153-166.
https://doi.org/10.1080/10408363.2020.1829537
|
[6]
|
Zajac-Spychala, O., Irga-Jaworska, N., Drozynska, E., Muszynska-Roslan, K., Krawczuk-Rybak, M., Zawitkowska, J., et al. (2020) Mixed Phenotype Acute Leukemia: Bio-logical Profile, Clinical Characteristic and Treatment Outcomes: Report of the Population-Based Study. European Journal of Haematology, 105, 85-93.
https://doi.org/10.1111/ejh.13413
|
[7]
|
Charles, N.J. and Boyer, D.F. (2017) Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls. Archives of Pathology & Laboratory Medicine, 141, 1462-1468. https://doi.org/10.5858/arpa.2017-0218-RA
|
[8]
|
Gutierrez, A. and Kentsis, A. (2018) Acute Mye-loid/T-Lymphoblastic Leukaemia (AMTL): A Distinct Category of Acute Leukaemias with Common Pathogenesis in Need of Improved Therapy. British Journal of Haematology, 180, 919-924. https://doi.org/10.1111/bjh.15129
|
[9]
|
Matutes, E., Pickl, W.F., Van’t Veer, M., Morilla, R., Swansbury, J., Strobl, H., et al. (2011) Mixed-Phenotype Acute Leukemia: Clinical and Laboratory Features and Outcome in 100 Patients De-fined According to the WHO 2008 Classification. Blood, 117, 3163-3171. https://doi.org/10.1182/blood-2010-10-314682
|
[10]
|
Porwit, A. and Bene, M.C. (2019) Multiparameter Flow Cy-tometry Applications in the Diagnosis of Mixed Phenotype Acute Leukemia. Cytometry Part B: Clinical Cytometry, 96, 183-194. https://doi.org/10.1002/cyto.b.21783
|
[11]
|
Alexander, T.B., Gu, Z., Iacobucci, I., Dickerson, K., Choi, J.K., Xu, B., et al. (2018) The Genetic Basis and Cell of Origin of Mixed Phenotype Acute Leukaemia. Nature, 562, 373-379. https://doi.org/10.1038/s41586-018-0436-0
|
[12]
|
Wolach, O. and Stone, R.M. (2015) How I Treat Mixed-Phenotype Acute Leukemia. Blood, 125, 2477-2485.
https://doi.org/10.1182/blood-2014-10-551465
|
[13]
|
Arber, D.A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M.J., Le Beau, M.M., et al. (2016) The 2016 Revision to the World Health Organization Classification of Myeloid Neo-plasms and Acute Leukemia. Blood, 127, 2391-2405.
https://doi.org/10.1182/blood-2016-03-643544
|
[14]
|
Rossi, J.G., Bernasconi, A.R., Alonso, C.N., Rubio, P.L., Gallego, M.S., Carrara, C.A., et al. (2012) Lineage Switch in Childhood Acute Leukemia: An Unusual Event with Poor Outcome. American Journal of Hematology, 87, 890-897.
https://doi.org/10.1002/ajh.23266
|